Givlaari 189 mg/ml
Givlaari 189 mg/ml is a medicine authorised by Swissmedic under authorisation number 67895. The authorisation holder is Alnylam Switzerland GmbH. The medicinal product code is Transplant: gene therapy product and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 March 2021 and the authorisation is valid without a time limit. ATC code A16AX places the medicine in the group Other alimentary tract and metabolism products.
| Authorisation number | 67895 |
|---|---|
| Name | Givlaari 189 mg/ml |
| Full name | Givlaari 189 mg/ml, Injektionslösung |
| Authorisation holder | Alnylam Switzerland GmbH |
| Medicinal product code | Transplant: gene therapy product |
| Dispensing category | B · Prescription only |
| ATC code | A16AX |
| First authorisation | 29 March 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Givlaari 189 mg/ml, Injektionslösung | B | 29 March 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | A16AX | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Givlaari 189 mg/ml authorised in Switzerland?
Yes. Givlaari 189 mg/ml is authorised by Swissmedic under authorisation number 67895, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Givlaari 189 mg/ml have?
Givlaari 189 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Givlaari 189 mg/ml?
The authorisation holder is Alnylam Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.